Core Viewpoint - The National Medical Insurance Administration (NMIA) has optimized the classification of medical consumables, enhancing the standardization and precision of medical insurance management in China [1][5]. Group 1: Classification Optimization - The optimization focuses on seven categories of medical consumables, including vascular intervention stents and balloons, non-vascular intervention stents and balloons, anastomosis devices, artificial organs, and implantable cardiac rhythm management devices [1][5]. - The new classification aims to objectively reflect the functional characteristics of various consumables, addressing issues related to identification, differentiation, and management [1][3]. Group 2: Coding and Price Monitoring - The classification is based on the registration information from the medical device regulatory authority, grouping consumables with similar clinical uses and structures under the same category [2]. - The introduction of unified coding for medical consumables allows for precise price monitoring, helping to identify and correct unfair pricing practices [2][4]. Group 3: Support for Innovation and Clinical Needs - The revised classification supports innovation by adding new categories for products already registered with the regulatory authority but lacking appropriate classification in the medical insurance database [4]. - The optimization aligns with clinical needs, facilitating better management and application of medical consumables, particularly in areas with significant differences in clinical use and insurance payment values [4][3]. Group 4: Implementation and Impact - This revision marks the first nationwide implementation of unified coding for medical consumables, with the new database already operational in regions like Shanghai [5]. - The optimization is expected to enhance data-driven decision-making in medical insurance management, addressing questions related to affordability and value [3].

记者从国家医保局获悉，目前，我国已完成血管介入支架、人工器官、植入式心脏节律管理器等7类医 保医用耗材的分类优化工作，将逐步解决医用耗材"识别难、区分难、管理难"等问题，提升了医保管理 的标准化、精细化水平。 长期以来，医用耗材产品命名缺乏统一标准，企业自主命名空间较大，致使市场上出现部分不同规格、 不同功能的产品共用同一名称，而部分本质相同的产品却拥有多个名称的现象，对医保的精准支付和基 金监管，以及医疗机构的耗材招标采购增添了难度。 为此，国家医保局2024年11月正式启动"医保医用耗材分类"修订。目前已完成分类优化工作的7类医保 医用耗材包括：血管介入支架、血管介入球囊、非血管介入支架、非血管介入球囊、吻合器、人工器 官、植入式心脏节律管理器。 此次医用耗材分类优化工作尊重支持创新，助推产业发展。例如，植入式无导线心脏起搏器是心脏起搏 领域的革命性技术，它可通过微创方式经静脉植入心腔内，具有无切口、无囊袋、无导线的优势。本次 分类调整将无导线心脏起搏器单独分类，充分关注了技术创新，为传统起搏器多次感染、上腔静脉通路 缺失、长期血液透析的患者提供了更多选择。 中国社会保障学会项目组负责人翟梦媛：我们的修订 ...